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In recent years there have been a plethora of
publications discussing man-made estrogen-
mimicking chemicals, the so-called xenoe-
strogens. Reports of declining semen quali-
ty (1) have been followed by hypotheses
that this phenomenon may be linked to an
increase in the exposure of humans to
xenoestrogens, specifically in utero (2).
Suspect chemicals originate from a variety
of backgrounds, many being anthropogenic
in origin, such as pesticides, detergents, and
plasticizers. One of the earliest endocrine
disruptors to be identified was the pesticide
DDT, the effects of which are discussed by
Fry and Toone (3). Other man-made
chemicals have since been recognized as
possessing estrogenic properties. For exam-
ple, 4-nonylphenol is the degradation prod-
uct of one group of nonionic surfactants,
the nonylphenol polyethoxylates, and expo-
sure to it has been demonstrated to induce
estrogenic effects both in vitro (4-6) and in
vivo (7). However, naturally occurring
xenoestrogens-including phytoestrogens,
such as coumestrol and genistein, and
mycoestrogens, such as zearalenone-also
exist; these may be found in plant food
stuffs, to which humans have always been
exposed (8).
Phthalates are just one of the many
classes of chemicals that have been implicat-
ed as having estrogenic properties. Evidence
of the estrogenic behavior of certain phtha-
lates in vitro has previously been reported
(9-11). Furthermore, an in vivo study has
shown the adverse effects of butyl benzyl
phthalate (BBP) on rat testes size and sperm
production (12). A report concerning an in
vivo multigenerational study investigating
the reproductive toxicity of dibutyl phtha-
late (DBP) in Sprague-Dawley rats has
recently been published. In this study, Wine
et al. (13) found that a number of reproduc-
tive parameters were adversely affected by
exposure to DBP administered via feed and
that, critically, the second generation
appeared more adversely affected than the
first generation in that most of the Fl males
were infertile. The mechanisms underpin-
ning these adverse reproductive effects are
unclear presently, but one possibility is that
some phthalates are estrogenic in vivo and
hence disrupt normal male development.
Phthalates are essentially used as plasti-
cizers in the production of polymeric
materials such as polyvinyl chloride (PVC),
imparting flexibility and workability, both
during the manufacturing process and to
the end product. When used in this way,
they are not chemically bound to the prod-
uct (14) and may therefore leach into the
surrounding medium (15).
Phthalates are produced in extremely
large volumes [the most widely used being
di(2-ethylhexyl) phthalate (DEHP), at
400-500 thousand tons per annum in
Europe alone; see Table 1] and have been
identified in all environmental compart-
ments. For example, they have been reported
in water, sediment, air and biota sampled
from the Gulf of Mexico (16), and river
water and sewage effluent samples from the
Greater Manchester area, United Kingdom
(1/). Food samples contaminated with
phthalates have also been reported (18-21).
The lipophilic nature of these chemicals indi-
cates that fatty foods such as cream, cheese,
and butter are most likely to be subject to
contamination. Sharman et al. (21) discov-
ered levels ofup to 1 14 mg/kg total phthalate
in cheese samples; however, the majority of
samples contained 0.6-3.0 mg/kg DEHP
and 4-20 mg/kg total phthalate. The authors
suggested that these high levels might have
arisen from environmental sources (for exam-
ple, from the wrappers surrounding the
cheese) rather than as a result of the diluted
presence of the contaminant in the raw com-
modity, followed by its distillation in the
fatty phase (21). Although these chemicals are
no longer used in most direct contact food
plastics and use in such materials has been
regulated for many years based on toxicologi-
cal data available and the fat content of the
food concerned (22), it is possible that other
sources of contamination during the manu-
facturing process, and from certain printing
inks and adhesives used in packaging, may
contribute to levels of phthalates found in
more recendy sampled foods (19).
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The possibility of such extensively used
chemicals as the phthalates having a detri-
mental influence on reproductive systems, of
either humans or wildlife, clearly causes
public concern, as is evident from the con-
siderable media coverage of this issue.
However, when phthalates are discussed,
they are often mistakenly referred to as a sin-
gle group of chemicals, with the assumption
that they all have similar properties, for
example estrogenic activity. In this paper we
investigate the ability of individual phthalate
esters to produce an estrogenic response in
vitro and attempt to relate this factor to their
occurrence as environmental contaminants,
as a partial contribution to an assessment of
their risk as endocrine disruptors.
Materials and Methods
Chemicals tested. 170-estradiol was pur-
chased from Sigma, Poole, United Kingdom.
Thirty-five phthalates, encompassing a
variety of structural and behavioral differ-
ences and including the major phthalates of
commercial importance, were purchased
from Greyhound Chemservice, Merseyside,
United Kindgom (Table 1). These were of
97-99% purity.
For comparison, a number of commer-
cial preparations were also obtained as gifts
from companies as follows: dibutyl phtha-
late (DBP, 99.7% pure), diisobutyl phtha-
late (DIBP, 99.6% pure), diethyl phthalate
(DEP, >99.7% pure), and dioctyl phthalate
(DOP, 99.9% pure), from BP Chemical
Ltd., Hull, United Kingdom; diisodecyl
phthalate (DIDP, 99.9%) and diisononyl
phthalate (DINP, 99.9%) from EXXON
Chemical Ltd., Fareham, United Kingdom;
ditridecyl phthalate (DTDP) from EXXON
Chemical Ltd., Courbevoie, France; and
butyl benzyl phthalate (BBP, >98.5%) from
Monsanto Europe S.A., Louvain-la-Neuve,
Belgium. Purity of these preparations is
given as provided by the company.
Various phthalate metabolites were
donated by R. Bos of the Department of
Toxicology, University of Nijmegen, The
Netherlands. These were mono-hexyl phtha-
late (MHP), mono-ethylhexyl phthalate
(MEHP), mono-pentyl phthalate (MPP),
mono-n-octyl phthalate (MnOP) and
metabolites V, VI, and IX of DEHP (23).
Also donated (by Monsanto Europe S.A.)
were the primary metabolites of BBP, mono-
butyl phthalate and mono-benzyl phthalate.
4-Nonylphenol, supplied by Schenectady
International Inc. (Schenectady, NY), bisphe-
nol A (Aldrich, Poole, U.K.), o,p'-DDT
(Greyhound Chemservice, Merseyside,
U.K.), and genistein (Sigma, Poole, U.K.)
were tested in the recombinant yeast screen
only, in order to demonstrate the activity and
potency of some known xenoestrogens.
Table 1. All the parent phthalate esters tested using the recombinant yeast screen
Phthalate name Abbreviation European consumption (tons/annum)
Bis(2-ethylhexyl) phthalate DEHP 400,000-500,000
Diisononyl phthalatea DINP 100,000-200,000
Diisodecyl phthalate DIDP 100,000-200,000
Butyl benzyl phthalatea BBP 20,000-50,000
Dibutyl phthalatea DBP 20,000-40,000
Diisobutyl phthalatea DIBP 20,000-40,000
Ditridecyl phthalate8 DTDP 3,000-10,000
Diethyl phthalatea DEP 10,000-20,000 (with DMP)
Dimethyl phthalate DMP 10,000-20,000 (with DEP)
Diisohexyl phthalate DIHP <2,000
Diundecyl phthalate DUP <2,000
Butyl decyl phthalate BDcP <1,000
Butyl octyl phthalate BOP <1,000
Dicyclohexyl phthalate DCHP <1,000
Dihexyl phthalate DHP Not alone
Di-n-octyl phthalate DnOP Not alone
Bis(2-n-butoxyethyl) phthalate DBoEP Negligible
Bis[2-(2-ethoxyethoxy)ethyl] phthalate DEoEoEP Negligible
Bis(ethoxyethyl) phthalate DEoEP Negligible
Bis(2-ethylhexyl) hexahydrophthalate DEHhP Negligible
Bis(2-ethylhexyl) isophthalate DEHIP Negligible
Bis(methoxyethyl) phthalate DMoEP Negligible
Butyl cyclohexyl phthalatea BCHP Negligible
Butyl 2-ethylhexyl phthalate BEHP Negligible
Butyl isodecyl phthalate BIDP Negligible
Diamyl phthalate DPeP Negligible
Dimethyl isophthalate DMIP Negligible
Dioctyl isophthalate DOIP Negligible
Diphenyl phthalatea DPhP Negligible
2-Ethylhexyl isodecyl phthalate EHIDP Negligible
Hexyl decyl phthalate HDP Negligible
Hexyl 2-ethylhexyl phthalate HEHP Negligible
Isodecyl tridecyl phthalate IDTDP Negligible
Octyl isodecyl phthalate OIDP Negligible
Isohexylbenzyl phthalatea IHBP Negligible
A ballpark consumption figure for each phthalate is given; "not alone" indicates that these particular
chemicals are not used individually but only in mixtures, in conjunction with other phthalates.
aPhthalates found to possess estrogenic activity in the screen.
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Figure 1. Estrogenic activity of some known environmental estrogens in the recombinant yeast screen.
17,B-estradiol serially diluted from 10-8 M and ethanol were used as positive and negative controls,
respectively. 4-Nonylphenol, o'p'-DDT, bisphenol A, and genistein are shown as standard curves serially
diluted from 10-5 M.
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3.0 1 2 1 11 S | |liigl|1Egt_go,p'-Bisphenol A was supplied by Dow
- I1*I Il7p-estradioI -Europe S.A., Horgen, Switzerland, and was
l 11 1 _* Ethanol Etested in the recombinant yeast screen to
I 31 !11II _1111_A DBP assess the possible significance of its presence
2. -il I DI 1NI _ |g !1I1 lBP _ DEHP as a contaminant in one of the phthalate
A DINPi h samples and its effect on the apparent estro-
A DINPi
_genicity of that sample.
2.0 The recombinant yeast screen. All
n') chemicals were assessed for estrogenic
activity using a recombinant yeast screen.
This is a cost-effective, sensitive, and spe-
(A cific process for detecting estrogenic activi-
oc ty. The screen has been described and
extensively validated elsewhere [see
__0 Routledge and Sumpter (24) for full
details]. Essentially, a gene for the human
estrogen receptor has been integrated into
the main yeast genome and is expressed in0.5 a form capable of binding to estrogen
10-12 10.11 10-10 io09 I o-B10-B7i~ 10-B i5 104 10f 102 response elements and controlling the
Molar concentration expression of the reporter gene Lac-Z. Thus,
3.0 1 1 _v L .- .- on activation of the receptor, the lac-Z
B - * ...7e.tradio. ..gene is expressed, producing the enzyme
* Ethanol galactosidase, which is secreted into the
* DTDP medium where it causes a color change of
2.5 thBCHP the chromogenic substance chlorophenolA IHBP red-p-D-galactopyranoside (CPRG) from
yellow to red. The intensity of the red color
2.0 __-- can be measured by absorbance.
1,
-The screen is highly specific for estro-
_
.. gens; androgens, progesterones and corti-
.0 costeroids are either completely inactive in
.0
°i5_ the screen or very weakly active at very high
o: _-_ concentrations (24).
Details of the preparation of medium
1.0 components and yeast stocks have been
_ _
~~~~~~~~~~~~~~~~~~~~publishedpreviously (24t).
Growth medium was prepared by adding
5 ml 20% w/v glucose solution, 1.25 ml 4
0.5 mg/m1 L-aspartic acid solution, 0.5 ml vita-
10.12 10-11 10.10 io-9 10- 10-7 104 10-5 1o-4 10-3 10-2 min solution, 0.4 ml 24 mg/ml L-threonine
Molar concentration solution, and 0.125 ml 20 niM copper (II)
sulfate solution to 45 ml single strength min-
3.0 e691 imal medium. The yeast culture was then
* 17,-estradiol prepared by seeding 50 ml growth medium
* Ethanol
* DHP
A DIHP - Figure 2. The estrogenic activity in the yeast
2.5... DMP screen of phthalate esters at concentrations rang-2.5 DUP ing from 10-3 M to 5 x 10-7 M, compared to 17p-
estradiol (serially diluted from 10-8 M). A) Illustrates
the estrogenic activity of phthalates consumed in
20 major volumes in Europe. B) Illustrates the estro-
genic activity of DEP and DTDP, which are used
commercially in Europe, and DPhP, BCHP, and
Ca IHBP, which are of negligible commercial usage.
.0
. .1.5 C Portrays the lack of estrogenic activity observedin the yeast screen when the cells were incubated
with certain phthalates. Abbreviations: BBP, butyl
benzyl phthalate; DBP, dibutyl phthalate; DIBP,
diisobutyl phthalate; DEHP, bis(2-ethylhexyl) phtha-
1.0 late; DIOP, diisodecyl phthalate; DINP, diisononyl
phthalate; DEP, diethyl phthalate; DTDP, ditridecyl
phthalate; DPhP, diphenyl phthalate; BCHP, butyl
cyclohexyl phthalate; IHBP, isohexylbenzyl phtha-0.5 late; DHP, dihexyl phthalate; DIHP, diisohexyl
10-12 10-11 10-1O io-9 10-8 10-7 10- i10-5 10-4 103 10-2 phthalate; DMP, dimethyl phthalate; DUP, diunde-
Molar concentration cyl phthalate.
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with 125 pl yeast stock and incubating this
overnight at 28°C on an orbital shaker. Assay
medium contained 0.5 ml 10 mg/ml
chlorophenol red-f-D-galactopyranoside
added to 50 ml growth medium seeded with
1 ml of the above yeast culture.
All glassware was thoroughly washed with
solvent. Test chemicals were made up in
ethanol to 2 x 10-2 M (phthalates), 2 x 104
M (4-nonylphenol, bisphenol A, genistein,
o,p'-DDT), or 2 x 10-7 M (17p3-estradiol)
stock solutions and stored at 40C.
Stock solutions were serially diluted in
ethanol, and 10 pl of each dilution was trans-
ferred to a 96-well microtiter plate
(Linbro/Titertek, ICN FLOW, Bucks,
U.K). This gave a final concentration of 10-3
M to 4.8 x 10-7 M for the phthalates and
their metabolites, 10-5M to 4.8 x 10-9M for
other xenoestrogens, or 10-8M to 4.8 x 10-12
M for 170-estradiol. Solvent controls were
set up on each plate using 10-pl aliquots of
ethanol. The ethanol was allowed to evapo-
rate and 200-pl aliquots of assay medium
(containing the yeast) was then added to each
well. The plates were then sealed with auto-
clave tape, shaken for 2 min on a titer-plate
shaker, and incubated at 320C for 4-6 days
in a naturally ventilated oven (WTIB binder,
BD-series; Jencons Scentific Ltd.,
Bedfordshire, U.K.). Plates were shaken on
day 1 of incubation and again approximately
1 hr before taking absorbance readings (540
nm for color and 620 nm for turbidity),
using a Titertek Multiskan MCC/340 plate
reader (Life Sciences Int., Basingstoke, U.K).
Mammalian cells. For comparison, the
proliferative effects of all commercially avail-
able phthalates showing estrogenic activity in
the recombinant yeast screen, as well as those
that were negative but of major volume use,
were tested using two estrogen-responsive
human breast cancer cell lines, MCF-7 and
ZR-75. As these cell lines are of human ori-
gin, they may be of particular relevance when
considering the wide exposure of humans to
the phthalates, which are ubiquitous in the
environment (25) and can be found in such
domestic products as vinyl flooring, chil-
dren's toys, printing inks, and cosmetics (26).
The phthalate samples used in these
assays were the analytical standards as sup-
plied by Greyhound Chemservice. Cells
were cultured in phenol red-free medium
containing 5% v/v charcoal dextran stripped
serum (DCC). They were then plated in 6-
well microtiter plates (Falcon, Becton
Dickinson, Lincoln Park, NJ) into the afore-
mentioned medium 3-4 days prior to com-
mencing the experiment. For the MCF-7
cells, medium was replaced with treated
medium containing either 0.1% vehide sol-
vent (ethanol) as a negative control, 10-8 M
17,-estradiol as a positive control, or 10-5
M of each respective phthalate. Cells were
trypsinized and counted using a Coulter
Counter (Coulter Electronics, Harpenden,
Herts, U.K.) on days 0, 2, 5, 8, and 12.
Treatments were duplicated and the experi-
ment was repeated twice. For the ZR75
cells, the treatments (control, 10-8 M, 10-10
M, and 10-12 M 17P-estradiol and 10-5 M,
10-6 M, and 10-7 M of individual phtha-
lates) were done in triplicate. Cells were
counted at a single endpoint on day 11.
Results
Table 1 lists the phthalate esters tested,
together with their consumption figures in
Europe, to give an idea of their impor-
tance relative to one another as industrial
chemicals. Some phthalates generated a
dose-dependent increase in 0-galactosidase
production in the yeast screen, indicating
weak estrogenic activity.
In order to relate the significance of the
activity of the estrogenic phthalates to that
of other environmental estrogens, we
assessed the response of the yeast screen to
a range of environmental estrogens. The
chemicals tested were bisphenol A (an
antioxidant), genistein (a phytoestrogen),
4-nonylphenol (the degradation product of
a surfactant), and o,p'-DDT (a pesticide);
Table 2. Phthalates found to give an estrogenic response in the yeast screen
Chemical
173-Estradiol
Diethyl phthalate
Dibutyl phthalate
Diisobutyl phthalate
Butyl cyclohexyl phthalate
Butyl benzyl phthalate
Diphenyl phthalate
Isohexylbenzyl phthalate
Diisononyl phthalate
Ditridecyl phthalate
Structure
OH
o
Ho0
110
,c,
0
0
oco
0
110
c
011o
co
6°0
0
0
lo
.
*
o0
co
Approximate
potencya,b
0.0000005
0.0000001
0.0000001
0.000001
0.0000001
Maximum
response (%)b
100
30
35
30
20
50
10
20
15
95
Potency and response relative to 17,-estradiol were calculated from data obtained on day 6 of the assay.
Longer incubation times can increase the relative maximum response; thus, the values shown here apply
only to a specific set of conditions.
"lndicates the value was calculated at 25% of the maximum response.
bAll data shown here were obtained using analytical standards.
*Alkyl chains are composed of various branched isomers.
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the results are shown in Figure 1. These
chemicals were tested over a concentration
range of 10-5 M to 5 x 10-9 M, and were
found to have potencies varying from
approximately 104-105 times less than that
of the main natural estrogen, 17,-estradiol.
The estrogenic activities of the major
volume usage phthalates (those exceeding
20,000 ton/annum in Europe) in the yeast
screen are shown in Figure 2A. Of these six
major volume use phthalates, three pos-
sessed estrogenic activity (BBP, DBP, and
DIBP), two did
and one (DINP)
the screen. The f
the most active
latter three are t
industry. Two (
produced for DI
producible behai
yeast screen. DI
mean response
which a detectal
dase production
Figure 3. The activity of bisphenol A (rows A and B), o,p'-bisphenol A (ro%
and H) in the recombinant yeast screen. Bisphenol A and the ortho-pari
serially diluted (left to right) from 10-5 M. DTDP was serially diluted from 1C
(10 pi ethanol added to each of these wells).
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Figure 4. Development of the butyl benzyl phthalate (BBP) standard curv
curve can be seen to be developing to an almost maximal response in this
I not (DEHP and DIDP), was reproduced in three separate assays, but
behaved unreproducibly in differed in a further three in which DINP
former three phthalates were appeared completely inactive (DINP i).
of all those tested, and the The phthalates of relatively low or neg-
he most extensively used in ligible use in Europe (29 different ones)
dose-response curves were were assessed for estrogenic activity using
NP due to the slighdly unre- the yeast screen only. Relatively few of
vior of this chemical in the these (five in total) possessed any estrogenic
[NP ii (Fig. 2A) shows the activity; all others were inactive, even at the
of two standard curves in highest concentration tested (10-3 M) (Fig.
ble increase in ,-galactosi- 2B, 2C). The results obtained from the five
was observed. This pattern phthalates that showed estrogenic activity
are illustrated in Figure 2B. Of these, only
* n 4 ea-i.. ....-i..two(DEP and DTDP) are used commer-
cially in Europe.
All of the phthalates that showed activity
were very weak estrogens. The most potent,
BBP, was approximately 1 million-fold less
potent than estradiol (Table 2), making it
_-w N considerably less potent than other environ-
- S 0 mental estrogens such as bisphenol A,
(8g_f_ @ i ; nonylphenol, and o,p'-DDT. When chemi-
cals are so weakly estrogenic, it is entirely
- |i;i ti |XWrfeasiblethat it is not the chemical (in this
case the phthalate) itself which is intrinsical-
ly estrogenic, but rather that an impurity in
the chemical is estrogenic. Thus, before
labeling a chemical as a weak estrogen, it is
necessary to exdude the possibility that the
chemical is contaminated with an estrogenic
impurity. One way to address this issue is to
test a number of samples, of different origin,
of each phthalate possessing estrogenic activ-
ity. If all samples of a phthalate possess the
same degree of estrogenic activity, it is likely
ws D and E), and DTDP (rows G that that particular phthalate is intrinsically
-aisomer of this chemical were active, whereas if the different samples of a
l- M. Rows C and F are controls phthalate possess considerably different
potencies, it is then likely that the phthalate
itself is not estrogenic, but that some sam-
ples contain varying proportions of one or
more contaminants that are estrogenic.
3
__10To assess this possibility-that estrogenic
contaminants might be present in some
phthalates-commercial preparations of all
the major volume usage phthalates, including
DTDP and DEP, were assessed for estrogenic
activity and their potencies compared to that
of their respective analytical standards (data
not shown). With one exception, no differ-
ences were observed; the estrogenic activities
_==------ of the commercial preparations were equiva-
lent to those of their respective analytical
standards. However, contrary to the analyti-
cal standard, the commercial preparation of
DTDP failed to produce a response, even
when present at 10-3 M. Both samples of
DTDP were subsequently analyzed by gel
chromatography-mass spectrometry (GC-
MS). The analytical standard (the active sam-
ple) was found to contain 0.5% of the ortho-
isomer of bisphenol A. The inactive prepara-
re over time. The BBP standard tion ofDTDP did not contain this chemical.
yeast assay. A sample of o,p'-bisphenol A was then
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obtained and its response in the yeast screen
was compared with that of the active DTDP
sample. Figure 3 shows that o,p'-bisphenol A
was about 100 times more potent than
DTDP. Therefore, the presence of this chem-
ical at just 0.5% in the DTDP sample would
produce a response equivalent to that seen.
Thus, it is likely that this chemical (o,p'-
bisphenol A) was responsible for the weak
activity observed in this phthalate sample (see
Fig. 1); hence DTDP is not estrogenic.
The results shown in Figure 2A and 2B
show that most of the active phthalates were
unable to produce a maximal response in the
yeast assay; only DTDP did so. For example,
the response to BBP (the most estrogenic
phthalate) reached a plateau at approximately
50% of the maximum response achieved with
17,B-estradiol. To determine whether this
means that most of the phthalates are only
partial estrogen agonists or whether other
explanations account for the submaximal
responses observed, a yeast screen containing
BBP was incubated for longer than usual and
the response was monitored daily. The results
(Fig. 4) show that on day 4 (the usual incuba-
tion time for our yeast assays) BBP produced
a shallow dose-response curve. However, by
day 6, the response was greater. By day 13 the
highest concentration ofBBP had produced a
maximal response. Note also that the
dose-response curve to 1713-estradiol moved
approximately fourfold to the left between
days 4 and 13 (i.e., the yeast screen became
more sensitive), but the dose-response curve
for BBP moved considerably further. Thus,
the potency of BBP increased somewhat with
time. For this reason, all the other phthalate
data shown in this paper was obtained from
yeast assays incubated for 6 days.
To assess whether the estrogenic
responses observed in the yeast assay were
reproducible in other estrogen assays, active
phthalates (plus the major volume use
phthalates, DEHP and DIDP) were also
tested for their ability to stimulate prolifera-
tion of MCF-7 and ZR-75 cells. The results
from these assays (Fig. 5 and Fig. 6), which
are based on human breast cancer cell lines,
are mostly comparable to those obtained
from the yeast screen. However, DEP and
DTDP failed to induce proliferation of ZR-
75 cells at 10-5, 10-6, or 10-7 M (Fig. SB)
although they had been active in the yeast
screen, albeit only at higher concentrations.
Using the ZR-75 cells, DINP at 10-5,10-6,
and 10-7 M induced proliferation to a sig-
nificantly greater extent than the control,
which is in contrast to our findings for this
chemical using the yeast screen. Growth
curves for all estrogenic phthalates (i.e.,
those active in the yeast assay) and for
DEHP and DIDP were obtained using
MCF-7 cells. The results (Fig. 6) showed
that BBP was considerably more mitogenic
than any of the other phthalates. DTDP,
DIBP, and DBP were approximately equiv-
alent in activity, and all the other phthalates
tested showed relatively little activity. All
these results are consistent with those
obtained using the yeast assay.
Possible additive or synergistic effects
between the most potent phthalates were
investigated by incubating known concentra-
tions of BBP, DBP, and 17[B-estradiol either
individually or as simple mixtures in the yeast
screen. The concentration of 170-estradiol
used produced only a small response above
background (Fig. 7), so that if additivity or
synergism occurred, they could be observed
within the range of the assay. Two concentra-
tions of each of the most active phthalates
(BBP and DBP) were tested alone and in
combination with 17p-estradiol. In all cases,
the response obtained was very close to that
expected if additivity had occurred (Fig. 7); in
no case was the response significantly greater
than predicted if additivity had occurred, that
is, no evidence ofsynergism was observed.
The phthalate metabolites tested
included 1) derivatives of the most abun-
dant phthalate (DEHP), namely MEHP
and metabolites V, VI, and IX (23); 2)
MBzP and MBuP, which are primary
metabolites of the most estrogenic phtha-
late (BBP); and 3) MHP, MnOP, and
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Figure 5. The proliferation of ZR-75 cells incubated with various phthalates and controls including time = 0 (t
= 0), ethanol, and 173-estradiol (data obtained from three separate assays). A) Cells incubated with butyl
benzyl phthalate (BBP), diisobutyl phthalate (DIBP), and dibutyl phthalate (DBP). B) Cells incubated with
diisononyl phthalate; (DINP), diethyl phthalate (DEP), and ditridecyl phthalate (DTDP). C) Cells incubated
with bis(2-ethylhexyl) phthalate (DEHP), diisodecyl phthalate (DIDP), and dihexyl phthalate (DHP). A simple
ANOVA was performed on the data, followed by the Bonferroni/Dunn test for multiple comparisons. Cell
numbers significantly greater than the control are denoted by *p<0.05; **p<0.01; #p<J.0OJ.
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Figure 6. This figure depicts the proliferation of MCF-I
ethanol, or iO-5 M of bis(2-ethylhexyl) phthalate (DEHP),
(DIBP), diisononyl phthalate (DINP), butyl benzyl phthal
late (DEP), or ditridecyl phthalate (DTDP) over a perioda
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Figure 7. The activity observed in the yeast screen whe
tons of butyl benzyl phthalate (BBP), dibutyl phthalate (D
mixtures. Abbreviations: A, 10-11 M 17,-estradiol; B, 10-41
Actual absorbance represents the corrected absorb
yeast minus that of the control). Theoretical absorbani
vidual treatments added together (the absorbance tha
in an additive manner).
MPeP. All were serially diluted from 10-3
M to 4.8 x 10-7 M, and none showed any
signs of estrogenic activity in the yeast
screen (data not shown).
Table 2 summarizes the relative poten-
cy and the magnitude of the responses
(compared to 17p-estradiol) of all phtha- '-
lates that were active in the yeast screen,
together with their structures.
g _ iof which is for DEHP, at up to 500,000
tons/annum in Western Europe. The
worldwide production of another class of
chemicals, the alkylphenol polyethoxylates,
was 360,000 tons/annum in the late 1980s
(27), which puts into perspective the large
scale use of phthalate esters as industrial
chemicals, as well as their potential envi-
ronmental importance.
In terms of their estrogenic behavior, it
seems that those phthalates requiring further
scrutiny indude 1) the shorter chain phtha-
_-_ 1 l lates, namely BBP, DBP, and DIBP, which
are used by industry in smaller quantities
(Table 1), but are more estrogenically active;
and 2) the longer chain phthalate DINP,
which although extremely weakly estrogenic
in vitro, is used in large quantities (up to
i(days) 200,000 tons/annum in Europe). The estro-genic behavior of the phthalates in these
7 cells incubated with 10-8 M 17(3-estradiol, 0.1% assays compares favorably to that previously
1, diisodecyl phthalate (DIDP), diisobutyl phthalate reported (9-11), where the potency of BBP
late (BBP), dibutyl phthalate (DBP), diethyl phtha- (approximately 1 millionfold less potent than
if 12 days. estradiol in the yeast screen) was similar to
that reported by Soto et al. (10,11) in the E-
SCREEN assay (3 millionfold less potent
than estradiol) and the relative strengths of
BDBP W. the phthalates reported to be estrogenic by
' #_.Actual absorbance _ Jobling et al. (9) correspond to that observed
-nTheoretical absorbance ~in the yeast screen (BBP>DBP). It must also
be noted that, generally speaking, the activi-
ties of the phthalates in the recombinant
yeast screen were reproduced in the mam-
malian assays, thus implying that these are
real estrogenic effects, and not artifactual.
There were occasional discrepancies between
assays: DTDP and DEP were not found to
be mitogenic in the ZR-75 cell line, but they
had shown slight mitogenic activity in the
MCF-7 assay and a positive response in the
recombinant yeast screen. The yeast cells are
more robust than mammalian cells and so
could be exposed to higher concentrations of
phthalates with no adverse effects, hence, the
observation of activity at the higher c-oncen-
A+1B A+C A+D A+E B+E C+E trations applied in the yeast screen. The rea-
Treatment sons for discrepancy between the two mam-
malian assays are undear, but may be a result
n yeast cells were incubated with single concentra- Of the enhanced proliferation of the MCF-7
)BP), and 17p-estradiol, either individually or in simple cell line*in the presence of growth factorsM BBP; C, 10-5M BBP; D, 104 M DBP; E, i0-5 M DBP. ( theidesenceof growth as
ance figure (the absorbance read for the treated (the identity of which iS not known), as
ce is the corrected absorbance of the relevant indi- compared to the ZR-75 cell line, which is
it would be expected if the two chemicals behaved more estrogen specific.
All active chemicals, however potent, are
said to be active because they cause a
Discussion ~ response above the baseline. However, for
In this paper, we investigate the possible all active phthalates, only a partial dose
estrogenic behavior of a large number of response was observed after the usual incu-
phthalate esters in vitro. As far as we are bation time. For example, for DINP, the
aware, this is the first paper to address indi- most used of all the active phthalates, the
vidual estrogenic potencies for such a compre- maximum response was just 15% of the
hensive spectrum of this dass ofchemicals. maximum response obtained with 17,B-
The phthalates studied are used by estradiol. A possible explanation for results
industry in variable amounts, the greatest such as these, which suggest partial agonistic
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behavior of the phthalates, is that these
chemicals were not fully solubilized in the
water-based medium employed in these
assays. This is a situation frequently encoun-
tered when applying highly organic com-
pounds to in vitro assays and is entirely feasi-
ble since, generally speaking, the solubility
values for phthalates are lower than the con-
centrations used in these trials. Thus, it is
plausible that some of the phthalates tested
are actually more potent than they appear to
be. However, it must be noted that the
chemical treatments were added to the
medium of the mammalian cell assays in
ethanol, thus leading to greater homogeneity
throughout, and still only a partial response
was observed. Conversely, contamination of
a chemical with an estrogenic compound
can imply a weak estrogenicity of the sub-
stance in question when it is, in fact, the
contaminant that is generating the observed
response and the chemical under investiga-
tion is not estrogenically active. This phe-
nomenon was detected in the case of
DTDP, where the weakly estrogenic prepa-
ration was found to be contaminated with
the ortho-isomer of bisphenol A. Hence,
caution must be applied when labeling a
chemical a weak estrogen, particularly if the
chemical is not pure (which is usually the
case, especially with industrial chemicals).
It has been reported that there is a rela-
tionship between the structure of a chemi-
cal and its estrogenic behavior (28). Of the
total number of phthalates tested in our
study, five possessed a secondary ring struc-
ture (BBP, BCHP, DPhP, IHBP, DCHP);
of these, the first four were all weakly estro-
genic, albeit with varying potencies.
However, by no means was this the key to
estrogenicity. Of those considered to be
estrogenically active, there were several that
possessed alkyl side-chains, and of these, a
greater maximum response was obtained
with DBP, DIBP, and DEP than by those
with a secondary ring structure. It appeared
that the majority of the active phthalates
were among the lower molecular weight
species, but again there were inconsisten-
cies with this observation, with many of
the lighter phthalates being inactive in the
recombinant yeast screen. It is therefore
difficult to deduce, from their two-dimen-
sional structures alone, which phthalate
esters will elicit estrogenic responses.
If a chemical exhibits only weak estro-
genic activity in vitro, it does not necessarily
follow that the effect of the same chemical
will be insignificant when applied to a
whole organism. Unfortunately, results of
the nature obtained here cannot be directly
extrapolated to an in vivo situation. It is not
known at present whether any phthalates
are estrogenic in vivo, and it will be neces-
sary to test these chemicals in vivo via dif-
ferent routes of exposure before reaching
conclusions. Although in vitro assays give us
an idea of the potential strength of a chemi-
cal as a xenoestrogen, they cannot simulate
changes to the chemical within an organism
and differences in the systems of individual
organisms, which may influence the poten-
cy and/or bioavailability of the chemical.
Metabolic processes will vary greatly,
depending on the route of uptake and on
the characteristics of both the chemical and
the organism concerned.
Another difficulty in estimating the
environmental hazard posed by phthalate
esters is the lack of data documenting the
exposure of humans or wildlife to these
chemicals. The fact that phthalates are used
in a wide variety of extensively used goods
is indisputable. It is also known that they
can exude from these products. For exam-
ple, DBP has been found to leach from
dentures (29), as has DINP from milk tub-
ing (30). Furtmann (31) has suggested that
the main source of phthalates are the con-
sumer products themselves and that there is
some justification in the inference that, fol-
lowing dumping or incineration of these
products, there are considerable phthalate
emissions into the environment. The esti-
mated total loss of phthalate esters in
Western Europe has been put at 7,740
tons/annum, or approximately 1% of total
consumption (32). However, the use of
such data in the analysis of environmental
hazard assessment for individual chemicals
is problematic because the data is general-
ized and estimates refer to total phthalates.
By far the most frequently reported
phthalate, and that found at highest concen-
trations in the environment, is DEHP. This
is to be expected, considering its high usage
and greater likelihood of persistence relative
to the shorter chain phthalates. For this rea-
son, one would also expect DIDP and
DINP to be apparent in environmental
samples, but reports concerning these
phthalates are sparse. Other phthalates that
have been regularly documented in food
(19,20), air (33,34), sediments (31,35), and
river water (36,37) include the lower molec-
ular weight phthalates such as DMP, DEP,
DBP, and BBP. These are less stable as plas-
ticizers and are therefore liable to migrate
from a polymer matrix, particularly when
this material is subjected to elevated temper-
ature or surrounded by a lipophilic medium.
For this reason, despite lower consumption
of these phthalates compared to the higher
molecular weight species, it is perhaps not
surprising for them to be commonly detect-
ed, albeit at very low concentrations, in
environmental samples. The solubility and
environmental persistence of individual
phthalates is somewhat dependent upon the
chain length of the phthalate concerned.
[For a more detailed discussion of the
behavior of phthalates in the aquatic envi-
ronment, see Furtmann (31)]. It must also
be considered that these chemicals are not
present in isolation in environmental sys-
tems. In any one system, various mixtures of
toxic organic chemicals can be found. For
example, a cocktail of trace organics was
documented in alligator eggs in Lake
Apopka, Florida (38). Phthalates themselves
have been found in environmental samples
alongside polychlorinated biphenyls, p,p'-
DDT, and p,p'-DDE (34). Certain of the
PCB congeners, for example 3,4,3',4'-tetra-
chlorobiphenyl, have been identified as
estrogen mimics (39), whereas p,p'-DDT
and p,p'-DDE have both been reported to
possess antiandrogenic properties (40). In
addition, various combinations of phthalates
have been found to be present in environ-
mental samples (37,41). With the possibility
that any contaminated environmental sam-
ple will contain more than one endocrine
disrupting chemical, it seems necessary to
investigate whether the effect of a combina-
tion of these chemicals will be additive,
more than additive, or antagonistic. This
issue was addressed by incubating simple
combinations of 17p-estradiol and two
estrogenic phthalates (BBP and DBP) in the
recombinant yeast screen. Jobling et al. (9)
found DBP and BBP, in the presence of
170-estradiol, to have an agonistic, as
opposed to antagonistic, effect on the stimu-
lation of transcriptional activity in transfect-
ed MCF-7 cells. We demonstrate in this
paper that the activity of combinations of
two phthalates, DBP and BBP, at the con-
centrations shown (Fig. 7) are, in fact,
slightly less than additive. When these
chemicals were incubated in the presence of
17p-estradiol (with BBP at a concentration
that would induce a less than maximal
response), the behavior of the combination
was again additive rather than synergistic.
Another factor influencing the occur-
rence of phthalates in the environment is
their potential for persisting and accumulat-
ing in organic matrices. This would be
expected to be high because phthalates are
hydrophobic chemicals; thus, it might be
possible to predict their environmental fate
pattern based on that of other man-made
organic chemicals. For example, the poly-
chlorinated biphenyls (42) and 4-nonylphe-
nol (43) bioaccumulate in organisms that are
exposed to these chemicals over a period of
time, and they also biomagnify through the
food chain. However, phthalates appear to
be more readily metabolized than these per-
sistent chemicals, particularly by enzymes in
the gut (44) and in sewage treatment works,
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although their rate of degradation does
appear to be influenced by the length of their
side chains (45,46). It is not known whether
the yeast strain employed in the assays shown
in this paper is capable of metabolizing com-
plex organic chemicals, although methoxy-
chlor has shown a positive response in the
recombinant yeast screen (47); and it has
been reported that this chemical must be
metabolized before it becomes estrogenically
active (48), thus suggesting that the yeast
strain is capable of degrading certain organic
chemicals. A small number of phthalate
metabolites were tested in the recombinant
yeast screen, including monobutyl phthalate
(the primary metabolite of DBP and DIBP)
and monobenzyl phthalate (which, with
monobutyl phthalate, are the primary
metabolites of BBP). All metabolites tested
were inactive in this assay, suggesting that it
is the parent compounds which are estro-
genic. This is significant in that, as previous-
ly discussed, the phthalates appear to be
metabolized following oral exposure, and
hence the monoesters are more likely to be
the bioavailable form of phthalates.
It is conceivable that the route of expo-
sure of an organism to phthalates is an
important parameter when considering
metabolism of these chemicals in vivo. It
seems probable that phthalates are readily
metabolized in the gut, such that oral expo-
sure would not lead to accumulation of
high concentrations of these chemicals.
However, there is little data available on the
metabolism of this group of chemicals fol-
lowing inhalation or dermal exposure. It is
perhaps necessary to investigate the fate of
phthalates within an organism following
administration via these routes, judging by
the presence of these chemicals in a wide
array of contact media. In addition, uptake
via the gills, hence directly into the blood
system, as occurs in fish, may elicit respons-
es that other routes of exposure would not.
In summary, a small number of com-
mercially available phthalate esters (BBP,
DIBP, DBP, DEP, DINP) are capable of
acting as extremely weak estrogens in vitro.
How this is relevant to the environment
cannot yet be directly estimated, partly
because comprehensive data concerning the
environmental fate and behavior of these
individual phthalates is not available and
partly due to the impracticalities involved
with extrapolating in vitro data to a whole
animal situation. The phthalate most wide-
ly used by the plastic industry, and that
reported on with greatest frequency, is
DEHP. This phthalate did not show estro-
genic activity in the assays employed in this
paper. Laboratory biodegradation studies,
particularly of the shorter chain phthalates
(that is, those which are the more potent
xenoestrogens), might imply that concen-
trations in the environment as a whole, and
within an organism, would not reach values
high enough to be of significant danger.
Although the potential exists for the above-
mentioned chemicals to generate adverse
effects when present within the system of an
organism, the concentrations and the con-
ditions of exposure required to do so are
unknown. Also note that this paper has
investigated one mechanism of action only,
that is, the ability of phthalates to act as
estrogen agonists. This may be just one of
many pathways that might lead to adverse
reproductive effects in animals exposed to
these chemicals. The results of in vivo
experiments, such as those reported by
Sharpe et al. (12) and Wine et al. (13), may
not be due solely to the weak estrogenic
activities of the particular phthalates admin-
istered, but may involve other, and possibly
more important, mechanisms of action. For
example, DEHP has been recognized for
many years to be a reproductive toxicant
(49-52), yet this particular phthalate
demonstrated no estrogenic behavior in the
assays employed in this study. It may also
transpire that it is not simply a matter of
the response of a parent organism to the
chemical concerned, whether exposure is
acute or chronic, but that any effect may
not be detected until subsequent genera-
tions. This possibility has been very clearly
demonstrated by Wine et al. (13), who
found that adverse reproductive effects
induced by DBP in Sprague-Dawley rats
were most pronounced in the second gener-
ation although the mechanisms generating
these responses are unknown.
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Participants will receive the scientific information necessary for a sound comprehension of the results
of nonclinical safety studies. Toxicologists and toxicologic pathologists will also benefit from this
Course by updating their knowledge. The course will be held on October 26-31, 1997 at the Crowne
Plaza in the heart of White Plains, New York, just 35 minutes north of New York City.
For a brochure and registration information, please contact
Nancy Rivera at the American Health Foundation, 1 Dana Road, Valhalla, NY 10595-1599.
Telephone: 914-789-7144, Fax: 914-592-6317.
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